OpenPV Signal Explorer
FAERS disproportionality dashboard
Reaction

Exfoliative Rash reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,589 reports · 51 co-occurring drugs

As of the last recalculation, Exfoliative Rash appears in 2,589 FAERS reports alongside 51 co-occurring drug terms. The strongest observed disproportionality signal is RIFAMPICIN (PRR 16.0).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Rifampicin2016.016.0
Icodextrin, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride5715.115.1
Epoetin Alfa138.98.9
Anakinra188.88.8
Meropenem348.68.6
Dalteparin Sodium107.67.6
Minocycline117.67.6
Sennosides 8.6 Mg Tablets197.37.3
Senna197.37.3
Terbinafine Hydrochloride87.37.3
Panitumumab147.27.2
Erlotinib Hydrochloride117.17.1
Clobetasol Propionate Ointment Usp, 0.05%97.07.1
Clobetasol Propionate97.07.0
Drs. Clotrimazole107.07.0
Family Wellness Clotrimazole107.07.0
Clotrimazole Topical107.07.0
Gentamicin116.86.8
Senna Leaf196.76.7
Erlotinib86.76.7
Clotrimazole106.66.6
Linezolid236.36.3
Sorafenib166.26.2
Sennosides226.06.0
Vancomycin Hydrochloride475.85.8
Gentamicin Sulfate115.65.6
Vancomycin395.55.5
Apalutamide85.55.5
Triamcinolone Acetonide Ointment Usp, 0.05%155.25.2
Cetuximab205.25.2
Nemolizumab-Ilto85.15.1
Regorafenib74.94.9
Memantine84.74.7
Memantine Hydrochloride84.74.7
Lapatinib84.24.2
Dupilumab2304.14.1
Paricalcitol63.43.4
Crisaborole43.43.4
Vemurafenib53.33.3
Peginterferon Alfa-2A213.13.1
Pemetrexed Disodium143.03.0
Methoxy Polyethylene Glycol-Epoetin Beta42.92.9
Emtricitabine And Tenofovir Alafenamide42.82.8
Belimumab102.52.5
Lenalidomide1032.02.0
Pirfenidone102.02.0
Cabozantinib111.81.8
Cinacalcet Hydrochloride101.71.7
Apremilast221.21.2
Evolocumab180.90.9
Adapalene60.30.3

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.